Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sohaib Hashmi

Orthopaedic Surgery of the Spine Orange, CA Medical Doctor

NPI 1982022281 CMS profile 2787795

101 The City Dr S Bldg 29A, Orange, CA 92868

Open in the dashboard

General payments

$181,918

348 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sohaib Hashmi of Orange, CA is reported in the CMS Open Payments database as having received $181,918 across 348 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,557 82
2024 General $20,996 72
2023 General $76,137 86
2022 General $7,834 34
2021 General $24,713 39
2020 General $16,985 15
2019 General $3,697 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sohaib Hashmi
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Sohaib Hashmi were reported at $31,557. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Sohaib Hashmi Orthopaedic Surgery of the Spine median Middle half National median
2019 $3,697 $2,106 $337–$18,608 $163
2020 $16,985 $1,213 $156–$15,082 $114
2021 $24,713 $1,834 $271–$15,617 $132
2022 $7,834 $2,015 $320–$17,036 $149
2023 $76,137 $1,925 $336–$14,599 $160
2024 $20,996 $2,110 $341–$12,483 $164
2025 $31,557 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SI-BONE, Inc. $37,193 56 payments
  2. NuVasive, Inc. $32,852 27 payments
  3. Life Spine, Inc. $25,218 26 payments
  4. Alphatec Spine, Inc $24,285 37 payments
  5. Orthofix Medical, Inc. $22,765 30 payments
  6. Globus Medical, Inc. $10,997 34 payments
  7. Neo Spine USA Inc $7,702 15 payments
  8. Kuros Biosciences USA, Inc $7,480 25 payments
  9. Stryker Corporation $4,577 27 payments
  10. Medtronic, Inc. $2,418 13 payments
  11. Other $6,433 58 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $92,525 33 payments
  2. Travel and Lodging $36,535 67 payments
  3. Grant $32,117 3 payments
  4. Food and Beverage $18,956 241 payments
  5. Royalty or License $1,459 3 payments
  6. Education $327 1 payment
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $23,705 13 payments
  2. ProLift Lateral Helo $21,062 12 payments
  3. REGATTA LATERAL SYSTEM $14,870 3 payments
  4. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $11,077 20 payments
  5. Arx $10,561 9 payments
  6. Other - Miscellaneous $8,326 9 payments
  7. Neo Pedicle Screw System $7,702 15 payments
  8. MAGNETOS $7,480 25 payments
  9. Mariner MIS $5,336 4 payments
  10. Clavical Fixation (16-186) $5,243 1 payment
  11. Other $55,149 252 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

304

Median for Orthopedic Surgery: 203

Drug cost

$5,316

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 96 $3,566
Gabapentin Generic 131 $1,315
Methocarbamol Generic 20 $196
Meloxicam Generic 38 $178
Methylprednisolone Generic 19 $61

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$226,288

Medicare's payments for the services billed

Medicare patients

394

Average age 74

Services billed

1,046

229 women, 165 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Depression 34%
Ischemic heart disease 33%
Osteoporosis 33%
Diabetes 32%
Chronic kidney disease 29%
Heart failure 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

348 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record